The American Medical Society for Sports Medicine (AMSSM) and OpenEvidence today announced a partnership that will focus on co-developing AI-powered educational resources on sports medicine for both patients and clinicians. This exclusive collaboration brings the expertise of AMSSM’s sports medicine physicians to OpenEvidence, the leading AI-powered clinical decision support platform, and will build on the AMSSM’s robust foundation of educational materials.

Together, AMSSM and OpenEvidence will create a library of resources and information about current and emerging topics in sports medicine for SportsMedToday.com, which already features more than 300 tip sheets on a wide range of sports medicine topics and conditions. These materials will be freely available on SportsMedToday and on OpenEvidence’s clinician website, which has supported over 200 million AI-powered clinical consultations from U.S. doctors and other frontline clinicians.

“It is vital for AMSSM to embrace technology to stay on the forefront of scientific progress,” said AMSSM Immediate Past President Dr. Carly Day. “We are honored that OpenEvidence saw value in the knowledge our members can provide to refine educational content for patients and providers.”

As AMSSM’s exclusive GenAI partner, OpenEvidence will assist in the development of sports medicine resources for clinicians across the entire medical landscape. By combining advanced AI capabilities with human specialist review, this collaboration will increase scale and quality: more sports medicine conditions covered, more frequently updated, and more readily available to clinicians and for patient and athlete education.

“Musculoskeletal disorders are the second leading reason for U.S. primary care visits. By combining the AI powered capabilities of OpenEvidence in synthesizing the latest medical evidence with AMSSM sports medicine specialist review, we are building the go-to patient and provider education resources to meet the needs of sports team physicians to front line clinicians and the athletes and patients that they serve,” said Cindy Lin MD, a sports medicine physician and VP of Digital Health at OpenEvidence.

“Together, AMSSM and OpenEvidence will bridge the gap between evolving sports medicine knowledge and patient education, supporting better informed care and giving clinicians, patients, athletes, and sports teams access to the latest evidence on sports injuries, rehabilitation, and recovery,” said Dr. Travis Zack, Chief Medical Officer at OpenEvidence.

About the American Medical Society for Sports Medicine

AMSSM is a multi-disciplinary organization of sports medicine physicians dedicated to education, research, advocacy and the care of athletes of all ages. The majority of AMSSM members are primary care physicians with fellowship training and added qualification in sports medicine who then combine their practice of sports medicine with their primary specialty. AMSSM includes members who specialize solely in non-surgical sports medicine and serve as team physicians at the youth level, NCAA, NFL, MLB, NBA, WNBA, MLS and NHL, as well as with Olympic and Paralympic teams. By nature of their training and experience, sports medicine physicians are ideally suited to provide comprehensive medical care for athletes, sports teams or active individuals who are simply looking to maintain a healthy lifestyle.

About OpenEvidence

OpenEvidence is the fastest-growing and most widely-used clinical decision support platform and medical search engine among U.S clinicians. According to independent studies, more American physicians use OpenEvidence than all other AI platforms combined. OpenEvidence is trusted by millions of verified healthcare professionals to make high-stakes clinical decisions at the point of care that are sourced, cited, and grounded in peer-reviewed medical literature. Founded with the mission to organize and expand the world’s collective medical knowledge, OpenEvidence is actively used daily, on average, by the majority of physicians in the United States. OpenEvidence is free for all verified U.S. clinicians. Learn more at www.openevidence.com.

Media gallery

About The Author
Business Wire